Static Systems Group has announced the appointment of Rosie Cunningham Thomas as the company’s new managing director.
Cunningham Thomas has more than 20 years of strategic and operational leadership in global corporates, SMEs, and start-ups.
And, over the past 12 years, she has specialised in leading and scaling early-stage, innovation-driven health technology companies through critical growth stages to full commercialisation and clinically-evidenced market acceptance.
She has prior medical CEO chief executive experience at Episurf Medical AB, ToHealth, and FreeHand 2010.
Prior to her business leadership roles, she held several senior commercial positions at Bard BD and Smiths Industries’ medical division.
Most recently, she was chief executive at NuVision Biotherapies, a leading regenerative medicine company which develops life-saving biomaterials.
Discussing her new role, she said: “I am delighted to be joining Static Systems Group (SSG) as it starts its next growth phase as part of Halma.
“The Turner family legacy is impressive, and together as SSG, we can honour this legacy while building for the future, creating sustainable and lasting value.”
